Cigarette Smoking is Associated with the Reduction of Lymphokine-activated Killer Cell and Natural Killer Cell Activities

Overview

Journal Environ Health Prev Med

Specialties Environmental Health
Public Health

Date 2011 Mar 25

PMID 21432415

Citations 4

Authors

C Inoue

T Takeshita

H Kondo

K Morimoto

Affiliations

Soon will be listed here.

Abstract

Lymphokine-activated killer (LAK) cell and natural killer (NK) cell activities were determined in a group of healthy individuals with differing smoking habits. The study population consisted of 54 Japanese males, including 23 smokers, 8 ex-smokers and 23 non-smokers. Peripheral blood mononuclear cells (PBMC) were isolated and used as effector cells. LAK cells were generated by incubation of PBMC with interleukin-2 for 72 h. LAK cell activity against NK-resistant Raji cells and NK cell activity against NK-sensitive K562 cells were examined by 4-h51Cr-release assay. LAK cell activity in the smokers was significantly lower than that in the nonsmokers. The smokers showed significantly lower NK cell activity than the nonsmokers, whereas NK cell activity of the ex-smokers was comparable to that of the non-smokers. The proportion of NK cells (CD3-16+56-, CD3-16-56+, or CD3-16+56+ cells) in the smokers was significantly lower than that in the nonsmokers. The present study demonstrates for the first time that cigarette smokers have lower LAK cell activity than nonsmokers.

Citing Articles

Mild Hyperbaric Oxygen Exposure Enhances Peripheral Circulatory Natural Killer Cells in Healthy Young Women.

Un Nisa B, Nakanishi R, Tanaka M, Lin H, Hirabayashi T, Maeshige N Life (Basel). 2023; 13(2).

PMID: 36836764 PMC: 9965672. DOI: 10.3390/life13020408.

The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma.

Patarat R, Riku S, Kunadirek P, Chuaypen N, Tangkijvanich P, Mutirangura A Sci Rep. 2021; 11(1):14838.

PMID: 34290294 PMC: 8295309. DOI: 10.1038/s41598-021-94330-1.

Novel DNA methylation signatures of tobacco smoking with trans-ethnic effects.

Christiansen C, Castillo-Fernandez J, Domingo-Relloso A, Zhao W, El-Sayed Moustafa J, Tsai P Clin Epigenetics. 2021; 13(1):36.

PMID: 33593402 PMC: 7888173. DOI: 10.1186/s13148-021-01018-4.

Mediating Effects of Patients' Stigma and Self-Efficacy on Relationships Between Doctors' Empathy Abilities and Patients' Cellular Immunity in Male Breast Cancer Patients.

Yang N, Cao Y, Li X, Li S, Yan H, Geng Q Med Sci Monit. 2018; 24:3978-3986.

PMID: 29891832 PMC: 6029513. DOI: 10.12659/MSM.910794.

References

Sone S, Inamura N, Nii A, Ogura T . Heterogeneity of human lymphokine (IL-2)-activated killer (LAK) precursors and regulation of their LAK induction by blood monocytes. Int J Cancer. 1988; 42(3):428-34. DOI: 10.1002/ijc.2910420320. View

Hercend T, Schmidt R . Characteristics and uses of natural killer cells. Immunol Today. 1988; 9(10):291-3. DOI: 10.1016/0167-5699(88)91317-5. View

Ginns L, Ryu J, Rogol P, Sprince N, Oliver L, Larsson C . Natural killer cell activity in cigarette smokers and asbestos workers. Am Rev Respir Dis. 1985; 131(6):831-4. DOI: 10.1164/arrd.1985.131.6.831. View

Grimm E, Ramsey K, Mazumder A, Wilson D, Djeu J, Rosenberg S . Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med. 1983; 157(3):884-97. PMC: 2186968. DOI: 10.1084/jem.157.3.884. View

Pross H, Baines M . Studies of human natural killer cells. I. In vivo parameters affecting normal cytotoxic function. Int J Cancer. 1982; 29(4):383-90. DOI: 10.1002/ijc.2910290404. View

Trinchieri G . Biology of natural killer cells. Adv Immunol. 1989; 47:187-376. PMC: 7131425. DOI: 10.1016/s0065-2776(08)60664-1. View

Onari K, Sadamoto K, Takaishi M, Inamizu T, Ikuta T, Yorioka N . Immunological studies on cigarette smokers. Part II: cell mediated immunity in cigarette smokers and the influence of the water-soluble fraction of cigarette smoke (WSF) on the immunity of mice. Hiroshima J Med Sci. 1980; 29(2):29-34. View

Phillips B, MARSHALL M, Brown S, Thompson J . Effect of smoking on human natural killer cell activity. Cancer. 1985; 56(12):2789-92. DOI: 10.1002/1097-0142(19851215)56:12<2789::aid-cncr2820561213>3.0.co;2-2. View

Grimm E, Robb R, Roth J, Neckers L, Lachman L, Wilson D . Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med. 1983; 158(4):1356-61. PMC: 2187385. DOI: 10.1084/jem.158.4.1356. View

10.

Hersey P, Prendergast D, Edwards A . Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust. 1983; 2(9):425-9. View

11.

Herberman R, Hiserodt J, Vujanovic N, Balch C, Lotzova E, Bolhuis R . Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen. Immunol Today. 2014; 8(6):178-81. DOI: 10.1016/0167-5699(87)90035-1. View

12.

Ferson M, Edwards A, Lind A, Milton G, Hersey P . Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer. 1979; 23(5):603-9. DOI: 10.1002/ijc.2910230504. View

13.

Grimm E, Owen-Schaub L . The IL-2 mediated amplification of cellular cytotoxicity. J Cell Biochem. 1991; 45(4):335-9. DOI: 10.1002/jcb.240450405. View

14.

Petersen B, Steimel L, Callaghan J . Suppression of mitogen-induced lymphocyte transformation in cigarette smokers. Clin Immunol Immunopathol. 1983; 27(1):135-40. DOI: 10.1016/0090-1229(83)90062-4. View

15.

Tollerud D, Clark J, Brown L, Neuland C, Mann D, Blattner W . Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis. 1989; 139(1):194-8. DOI: 10.1164/ajrccm/139.1.194. View

16.

Boyum A . Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl. 1968; 97:9-29. View

17.

Lindemann R, Park N . Inhibition of human lymphokine-activated killer activity by smokeless tobacco (snuff) extract. Arch Oral Biol. 1988; 33(5):317-21. DOI: 10.1016/0003-9969(88)90064-7. View

18.

Grimm E, Mazumder A, Zhang H, Rosenberg S . Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med. 1982; 155(6):1823-41. PMC: 2186695. DOI: 10.1084/jem.155.6.1823. View

19.

Miller L, Goldstein G, Murphy M, Ginns L . Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest. 1982; 82(5):526-9. DOI: 10.1378/chest.82.5.526. View

20.

Bubenik J . Local immunotherapy of cancer with interleukin 2. Immunol Lett. 1989; 21(4):267-73. DOI: 10.1016/0165-2478(89)90018-7. View